These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 9604687)

  • 61. Prolonged neuromuscular block after mivacurium in a patient with end-stage renal disease.
    Mangar D; Kirchhoff GT; Rose PL; Castellano FC
    Anesth Analg; 1993 Apr; 76(4):866-7. PubMed ID: 8466030
    [No Abstract]   [Full Text] [Related]  

  • 62. [Prolonged neuromuscular block induced by mivacurium].
    Bensaid A; Miloudi Y; El Harrar N
    Ann Fr Anesth Reanim; 2006 Apr; 25(4):462-3. PubMed ID: 16377125
    [No Abstract]   [Full Text] [Related]  

  • 63. [Prolonged neuromuscular blockade caused by mivacurium in a pediatric patient].
    Fernández-Rosado B; Vázquez-Fidalgo A; Pensado-Castiñeiras A; Figueira-Moure A; Rama-Maceiras P; Pose-Cambeiro P
    Rev Esp Anestesiol Reanim; 1999 Feb; 46(2):92. PubMed ID: 10100446
    [No Abstract]   [Full Text] [Related]  

  • 64. Muscle relaxants suitable for day case surgery.
    Geldner G; Wulf H
    Eur J Anaesthesiol Suppl; 2001; 23():43-6. PubMed ID: 11766246
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The importance of myorelaxants in anesthesia.
    Flood P
    Curr Opin Pharmacol; 2005 Jun; 5(3):322-7. PubMed ID: 15907920
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Prolonged muscle weakness associated with the administration of non-depolarizing neuromuscular blocking agents in critically ill patients].
    López MP; Seiz A; Criado A
    Rev Esp Anestesiol Reanim; 2001 Oct; 48(8):375-83. PubMed ID: 11674984
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Prevention of undesirable effects during the use of non-depolarizing muscle relaxants].
    Diefenbach C; Buzello W
    Klin Anasthesiol Intensivther; 1993; 42():132-51. PubMed ID: 8450621
    [No Abstract]   [Full Text] [Related]  

  • 68. [Do the severe side-effects of curare-like agents differ according the neuromuscular blocking agent?].
    Lepage JY; Laxenaire MC
    Ann Fr Anesth Reanim; 2000 Sep; 19 Suppl 2():367s-377s. PubMed ID: 11072563
    [No Abstract]   [Full Text] [Related]  

  • 69. [Progresses in anesthesiology in China, 1996].
    Luo A; Yang B
    Zhonghua Yi Xue Za Zhi; 1996 Dec; 76(12):914-6. PubMed ID: 9275580
    [No Abstract]   [Full Text] [Related]  

  • 70. Neuromuscular blocking agents in the intensive care unit: a two-edged sword.
    Sladen RN
    Crit Care Med; 1995 Mar; 23(3):423-8. PubMed ID: 7874888
    [No Abstract]   [Full Text] [Related]  

  • 71. [Mivacurium. A non-depolarizing neuromuscular blocking agent with short-lasting effect].
    Ostergaard D; Mogensen JV
    Ugeskr Laeger; 1998 Mar; 160(14):2126-30. PubMed ID: 9604687
    [No Abstract]   [Full Text] [Related]  

  • 72.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.